Firefly Neuroscience (AIFF) EV to EBITDA (2010 - 2026)

Firefly Neuroscience has reported EV to EBITDA for 16 years, with the latest figure at 7.94 in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 59.09% year-over-year to 7.94 in Q2 2026; TTM through Jun 2026 was 1.71, a 31.52% increase from a year earlier, with the FY2025 full-year figure at 1.08, up 30.29% from the prior year.
• EV to EBITDA was 7.94 for Q2 2026 at Firefly Neuroscience, up from 14.57 in the prior quarter.
• The five-year high for EV to EBITDA was 11.42 in Q2 2023, with the low at 52.82 in Q1 2022.
• Average EV to EBITDA over 5 years is 11.21, with a median of 9.03 recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: EV to EBITDA jumped 180.43% in 2023, then slumped 260.51% in 2025.
• Over 5 years, EV to EBITDA stood at 9.03 in 2022, then surged by 91.1% to 0.8 in 2023, then slumped by 361.39% to 3.71 in 2024, then declined by 2.9% to 3.82 in 2025, then slumped by 108.12% to 7.94 in 2026.
• The last three EV to EBITDA figures came in at 7.94 (Q2 2026), 14.57 (Q1 2026), and 3.82 (Q4 2025), per Business Quant data.